--- title: "Lepu Biopharma Co. (2157) stock: news and investor profile" url: "https://aibio.space/companies/lepu-biopharma/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "Lepu Biopharma Co. Ltd. (HKEX: 2157), China. The directory classifies it as Pharmaceuticals: Major." --- 2157 Lepu Biopharma Co. Ltd. HKEX · China # Lepu Biopharma Co. (2157) news Lepu Biopharma Co. Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 2157, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest Lepu Biopharma Co. news We have not published a story on Lepu Biopharma Co. yet. When there is news, it will appear here. ## Lepu Biopharma Co. at a glance - **Ticker**: 2157 - **Listing**: HKEX - **Country**: China ### Related companies - [Jiuzhitang Co.](https://aibio.space/companies/jiuzhitang/) SZSE: 000989 - [Zhejiang Huahai Pharmaceutical Co.](https://aibio.space/companies/zhejiang-huahai-pharmaceutical/) SSE: 600521 - [Ginwa Enterprise (Group)](https://aibio.space/companies/ginwa-enterprise/) SSE: 600080 - [Jiangsu Hengrui Pharmaceuticals Co.](https://aibio.space/companies/jiangsu-hengrui-pharmaceuticals/) SSE: 600276 - [Sichuan Kelun-Biotech Biopharmaceutical Co.](https://aibio.space/companies/sichuan-kelun-biotech-biopharmaceutical/) HKEX: 6990 - [Beijing Centergate Technologies (Holding) Co.](https://aibio.space/companies/beijing-centergate-technologies/) SZSE: 000931 - [Adagene](https://aibio.space/companies/adagene/) NASDAQ: ADAG - [Beijing Beilu Pharmaceutical Co.](https://aibio.space/companies/beijing-beilu-pharmaceutical/) SZSE: 300016 ### Also on HKEX - [Hua Medicine](https://aibio.space/companies/hua-medicine/) 2552 - [Nanjing Leads Biolabs Co.](https://aibio.space/companies/nanjing-leads-biolabs/) 9887 - [TYK Medicines](https://aibio.space/companies/tyk-medicines/) 2410 - [Brii Biosciences](https://aibio.space/companies/brii-biosciences/) 2137 - [Suzhou Ribo Life Science Co.](https://aibio.space/companies/suzhou-ribo-life-science/) 6938 - [Laekna](https://aibio.space/companies/laekna/) 2105 ## Questions about Lepu Biopharma Co. What is the ticker symbol of Lepu Biopharma Co.? Lepu Biopharma Co. Ltd. trades under the ticker 2157 on HKEX. Where is Lepu Biopharma Co. listed? Lepu Biopharma Co. Ltd. is listed on HKEX. Which country or territory is Lepu Biopharma Co. listed under? Our directory records Lepu Biopharma Co. Ltd. under China. What does Lepu Biopharma Co. do? Our directory classifies Lepu Biopharma Co. Ltd. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline. What is the ISIN of Lepu Biopharma Co.? The ISIN recorded for Lepu Biopharma Co. Ltd. is CNE100004SM4. Does aibio.space cover Lepu Biopharma Co.? aibio.space lists Lepu Biopharma Co. Ltd. among 2,820 public biotech companies and publishes its news here as stories appear. Which companies are similar to Lepu Biopharma Co.? Companies in our directory listed in the same country and business area as Lepu Biopharma Co.: Jiuzhitang Co., Zhejiang Huahai Pharmaceutical Co., Ginwa Enterprise (Group), Jiangsu Hengrui Pharmaceuticals Co., Sichuan Kelun-Biotech Biopharmaceutical Co., Beijing Centergate Technologies (Holding) Co.. ## Investor discussion: Lepu Biopharma Co. Members talk about Lepu Biopharma Co. (2157). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at Lepu Biopharma Co., newest first. Each line links the filing it comes from. 1. 2026-04-27 Financings Share or debt issue: (1) 2025 REPORT OF THE BOARD OF DIRECTORS (2) 2025 REPORT OF THE BOARD OF SUPERVISORS (3) 2025 ANNUAL REPORT (4) 2025 FINANCIAL ACCOUNTS REPORT (5) 2026 FINANCIAL BUDGET (6) 2025 ANNUAL PROFIT DISTRIBUTION PLAN (7) RE-APPOINTMENT OF AUDITOR (8) PROPOSED APPOINTMENT OF SUPERVISOR (9) PROPOSED CHANGE OF REGISTERED ADDRESS (10) PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION (11) GENERAL MANDATE TO ISSUE ADDITIONAL SHARES AND NOTICE OF THE 2025 ANNUAL GENERAL MEETING. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0427/2026042703004.pdf) 2. 2025-07-11 Financings Share or debt issue: COMPLETION OF PLACING OF NEW H SHARES UNDER GENERAL MANDATE. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0711/2025071100255.pdf) 3. 2025-07-04 Financings Share or debt issue: PLACING OF NEW H SHARES UNDER GENERAL MANDATE. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0704/2025070400053.pdf) 4. 2025-06-06 Financings Share or debt issue: (1) 2024 REPORT OF THE BOARD OF DIRECTORS (2) 2024 REPORT OF THE BOARD OF SUPERVISORS (3) 2024 ANNUAL REPORT (4) 2024 FINANCIAL ACCOUNTS REPORT (5) 2025 FINANCIAL BUDGET (6) 2024 ANNUAL PROFIT DISTRIBUTION PLAN (7) RE-APPOINTMENT OF AUDITOR (8) PROPOSED APPOINTMENT OF NON-EXECUTIVE DIRECTOR (9) GENERAL MANDATE TO ISSUE ADDITIONAL SHARES AND NOTICE OF THE 2024 ANNUAL GENERAL MEETING. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0606/2025060601505.pdf) ## Press releases Headlines of Lepu Biopharma Co.'s own announcements, newest first. Each opens the full release on the newswire that carried it. 1. 2026-10-26 HKEXnews [VOLUNTARY ANNOUNCEMENT CMG901 (AZD0901) CLINICAL RESULTS PRESENTED AS LBA PROFFERED PAPER AT PRESIDENTIAL SYMPOSIUM, MRG007 CLINICAL RESULTS PRESENTED AS LBA, AND ENCOURAGING DATA FOR MRG003 PRESENTED AS RAPID ORAL AT ESMO 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/1026/2026102600250.pdf) 2. 2026-09-23 HKEXnews [VOLUNTARY ANNOUNCEMENT FOUR CLINICAL STUDIES SELECTED FOR PRESENTATION AT 2026 ESMO CONGRESS: CMG901 (AZD0901) CLINICAL TRIAL RESULTS SELECTED AS LBA FOR PROFFERED PAPER PRESENTATION AT PRESIDENTIAL SYMPOSIUM, MRG007 CLINICAL TRIAL RESULTS SELECTED AS LBA FOR RAPID ORAL PRESENTATION, AND TWO OTHER STUDIES SELECTED FOR RAPID ORAL PRESENTATION](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0923/2026092300318.pdf) 3. 2026-08-19 HKEXnews [INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0819/2026081900408.pdf) 4. 2026-07-28 HKEXnews [VOLUNTARY ANNOUNCEMENT POSITIVE TOP-LINE RESULTS ACHIEVED FROM CLARITY-GASTRIC01 GLOBAL PHASE III TRIAL OF CMG901 (AZD0901)](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0728/2026072800183.pdf) 5. 2026-07-15 HKEXnews [CHANGE OF EMPLOYEE REPRESENTATIVE SUPERVISOR](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0715/2026071500382.pdf) 6. 2026-05-19 HKEXnews [ARTICLES OF ASSOCIATION](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0519/2026051901093.pdf) 7. 2026-05-19 HKEXnews [(1) POLL RESULTS OF THE 2025 ANNUAL GENERAL MEETING HELD ON MAY 19, 2026; (2) APPOINTMENT OF SUPERVISOR; (3) CHANGE OF REGISTERED ADDRESS AND (4) AMENDMENTS TO THE ARTICLES OF ASSOCIATION](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0519/2026051901083.pdf) 8. 2026-05-06 HKEXnews [DIS-APPLICATION OF RULES 18A.09 TO 18A.11 OF THE LISTING RULES AND REMOVAL OF STOCK MARKER](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0506/2026050602474.pdf) 9. 2026-04-27 HKEXnews [(1) PROPOSED APPOINTMENT OF SUPERVISOR; (2) PROPOSED CHANGE OF REGISTERED ADDRESS; AND (3) PROPOSED AMENDMENTS OF THE ARTICLES OF ASSOCIATION](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0427/2026042703044.pdf) 10. 2026-04-27 HKEXnews [(1) 2025 REPORT OF THE BOARD OF DIRECTORS (2) 2025 REPORT OF THE BOARD OF SUPERVISORS (3) 2025 ANNUAL REPORT (4) 2025 FINANCIAL ACCOUNTS REPORT (5) 2026 FINANCIAL BUDGET (6) 2025 ANNUAL PROFIT DISTRIBUTION PLAN (7) RE-APPOINTMENT OF AUDITOR (8) PROPOSED APPOINTMENT OF SUPERVISOR (9) PROPOSED CHANGE OF REGISTERED ADDRESS (10) PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION (11) GENERAL MANDATE TO ISSUE ADDITIONAL SHARES AND NOTICE OF THE 2025 ANNUAL GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0427/2026042703004.pdf) 11. 2026-04-27 HKEXnews [NOTICE OF THE 2025 ANNUAL GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0427/2026042702998.pdf) 12. 2026-03-25 HKEXnews [ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2025](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0325/2026032500375.pdf) 13. 2026-03-10 HKEXnews [VOLUNTARY ANNOUNCEMENT UPDATE ON COLLABORATION WITH ASTRAZENECA FOR ADC CANDIDATE CMG901 (AZD0901)](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0311/2026031100011.pdf) 14. 2026-03-10 HKEXnews [POSITIVE PROFIT ALERT](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0311/2026031100005.pdf) 15. 2025-12-18 HKEXnews [UPDATES ON LICENSING TRANSACTION](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/1218/2025121801395.pdf) 16. 2025-12-18 HKEXnews [POLL RESULTS OF THE 2025 SECOND EXTRAORDINARY GENERAL MEETING HELD ON DECEMBER 18, 2025](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/1218/2025121800956.pdf) 17. 2025-12-02 HKEXnews [AMENDMENTS TO THE ARTICLES OF ASSOCIATION](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/1202/2025120202096.pdf) 18. 2025-11-28 HKEXnews [NOTICE OF THE SECOND 2025 EGM](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/1128/2025112801788.pdf) 19. 2025-11-28 HKEXnews [(1) PROPOSED ADOPTION OF THE RESTRICTED SHARE UNIT SCHEME (H SHARE); AND (2) NOTICE OF THE SECOND 2025 EGM](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/1128/2025112801760.pdf) 20. 2025-11-28 HKEXnews [CONTINUING CONNECTED TRANSACTION CDMO SERVICES FRAMEWORK AGREEMENT](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/1128/2025112800534.pdf) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open HKEX:2157 on TradingView](https://www.tradingview.com/symbols/HKEX-2157/). ## Listing details Lepu Biopharma Co. Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 2157, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Lepu Biopharma Co. Ltd. - **Ticker**: 2157 - **Listing**: HKEX - **Country or territory**: China - **Business scope**: Pharmaceuticals: Major - **ISIN**: CNE100004SM4 - **Last quote in directory**: 2026-10-22 - **Directory source**: [Listing page](https://www.tradingview.com/symbols/HKEX-2157/) Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/lepu-biopharma/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Lepu Biopharma Co. (2157) stock: news and investor profile", 2026-10-31, https://aibio.space/companies/lepu-biopharma/